Detalhe da pesquisa
1.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
2.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
N Engl J Med
; 378(25): 2386-2398, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860938
3.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Blood
; 131(13): 1415-1424, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348128
4.
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proc Natl Acad Sci U S A
; 114(36): E7554-E7563, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784769
5.
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Blood
; 130(6): 722-731, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588020
6.
A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
Br J Haematol
; 181(4): 476-485, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663325
7.
Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.
Mod Pathol
; 31(3): 429-441, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192651
8.
A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy.
Int J Mol Sci
; 18(7)2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696354
9.
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
Am J Hematol
; 91(3): 277-82, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663264
10.
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
Br J Haematol
; 169(4): 534-43, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733005
11.
The role of inflammation in leukaemia.
Adv Exp Med Biol
; 816: 335-60, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24818729
12.
Evaluating targeted therapies in older patients with TP53-mutated AML.
Leuk Lymphoma
; : 1-18, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646877
13.
New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.
Future Oncol
; 9(5): 681-97, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23647297
14.
A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS).
Leuk Lymphoma
; 64(10): 1689-1694, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440338
15.
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Leukemia
; 37(9): 1915-1918, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524919
16.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Blood Adv
; 7(9): 1899-1909, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441905
17.
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.
Blood Cancer Discov
; 4(6): 452-467, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698624
18.
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.
Blood
; 115(18): 3796-800, 2010 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20203261
19.
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.
Blood
; 116(22): 4591-9, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20651072
20.
Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia.
Eur J Clin Invest
; 42(9): 1016-26, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22548456